194 related articles for article (PubMed ID: 22484652)
1. Class I recall of defibrillator leads: a comparison of the Sprint Fidelis and Riata families.
Liu J; Brumberg G; Rattan R; Jain S; Saba S
Heart Rhythm; 2012 Aug; 9(8):1251-5. PubMed ID: 22484652
[TBL] [Abstract][Full Text] [Related]
2. Transvenous extraction of implantable cardioverter-defibrillator leads under advisory--a comparison of Riata, Sprint Fidelis, and non-recalled implantable cardioverter-defibrillator leads.
Brunner MP; Cronin EM; Jacob J; Duarte VE; Tarakji KG; Martin DO; Callahan T; Borek PP; Cantillon DJ; Niebauer MJ; Saliba WI; Kanj M; Wazni O; Baranowski B; Wilkoff BL
Heart Rhythm; 2013 Oct; 10(10):1444-50. PubMed ID: 23816440
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Sprint Fidelis and Riata defibrillator lead failure rates.
Fazal IA; Shepherd EJ; Tynan M; Plummer CJ; McComb JM
Int J Cardiol; 2013 Sep; 168(2):848-52. PubMed ID: 23138013
[TBL] [Abstract][Full Text] [Related]
4. Failure-free survival of the Durata defibrillator lead.
Liu J; Patel D; Rattan R; Brumberg G; Saini A; Vaghasia N; Bazaz R; Adelstein E; Jain S; Saba S
Europace; 2013 Jul; 15(7):1002-6. PubMed ID: 23376976
[TBL] [Abstract][Full Text] [Related]
5. Failure of implantable cardioverter-defibrillator leads: a matter of lead size?
Rordorf R; Poggio L; Savastano S; Vicentini A; Petracci B; Chieffo E; Klersy C; Landolina M
Heart Rhythm; 2013 Feb; 10(2):184-90. PubMed ID: 23063430
[TBL] [Abstract][Full Text] [Related]
6. Long-term electrical survival analysis of Riata and Riata ST silicone leads: National Veterans Affairs experience.
Sung RK; Massie BM; Varosy PD; Moore H; Rumsfeld J; Lee BK; Keung E
Heart Rhythm; 2012 Dec; 9(12):1954-61. PubMed ID: 22871583
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcome of implantable cardioverter defibrillators with recalled and non-recalled leads in Japanese patients. Increased failure rate of the Sprint Fidelis lead.
Yanagisawa S; Inden Y; Shimano M; Yoshida N; Ichiyanagi H; Fujita M; Ohguchi S; Ishikawa S; Kato H; Okumura S; Miyoshi A; Nagao T; Yamamoto T; Hirai M; Murohara T
Circ J; 2014; 78(2):353-9. PubMed ID: 24270680
[TBL] [Abstract][Full Text] [Related]
8. Increased rate of subacute lead complications with small-caliber implantable cardioverter-defibrillator leads.
Ellis CR; Rottman JN
Heart Rhythm; 2009 May; 6(5):619-24. PubMed ID: 19389648
[TBL] [Abstract][Full Text] [Related]
9. Update on small-diameter implantable cardioverter-defibrillator leads performance.
van Rees JB; van Welsenes GH; Borleffs CJ; Thijssen J; van der Velde ET; van der Wall EE; van Erven L; Schalij MJ
Pacing Clin Electrophysiol; 2012 Jun; 35(6):652-8. PubMed ID: 22352338
[TBL] [Abstract][Full Text] [Related]
10. Comparison of longevity and clinical outcomes of implantable cardioverter-defibrillator leads among manufacturers.
Kawada S; Nishii N; Morimoto Y; Miyoshi A; Tachibana M; Sugiyama H; Nakagawa K; Watanabe A; Morita H; Ito H
Heart Rhythm; 2017 Oct; 14(10):1496-1503. PubMed ID: 28502870
[TBL] [Abstract][Full Text] [Related]
11. Comparison of lead failure manifestation of Biotronik Linox with St. Jude Medical Riata and Medtronic Sprint Fidelis lead.
Lam A; Buehler S; Goulouti E; Sweda R; Haeberlin A; Medeiros-Domingo A; Servatius H; Seiler J; Baldinger S; Noti F; Tanner H; Roten L
J Interv Card Electrophysiol; 2019 Mar; 54(2):161-170. PubMed ID: 30471050
[TBL] [Abstract][Full Text] [Related]
12. Comparative outcomes of transvenous extraction of sprint fidelis and riata defibrillator leads: a single center experience.
Richardson TD; Kolek MJ; Goyal SK; Shoemaker MB; Lewis AA; Rottman JN; Whalen SP; Ellis CR
J Cardiovasc Electrophysiol; 2014 Jan; 25(1):36-42. PubMed ID: 24028661
[TBL] [Abstract][Full Text] [Related]
13. A Comparative Study of Defibrillator Leads at a Large-Volume Implanting Hospital: Results From the Pacemaker and Implantable Defibrillator Leads Survival Study ("PAIDLESS").
Cohen TJ; Asheld WJ; Germano J; Islam S; Patel D
J Invasive Cardiol; 2015 Jun; 27(6):292-300. PubMed ID: 26028656
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal follow-up of implantable cardioverter defibrillator leads.
Liu J; Brumberg G; Rattan R; Patel D; Adelstein E; Jain S; Saba S
Am J Cardiol; 2014 Jan; 113(1):103-6. PubMed ID: 24176060
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcomes in patients with implantable cardioverter defibrillators and Sprint Fidelis leads.
Verlato R; Facchin D; Catanzariti D; Molon G; Zanotto G; Morani G; Brieda M; Zanon F; Delise P; Leoni L; Comisso J; Campo C
Heart; 2013 Jun; 99(11):799-804. PubMed ID: 23434626
[TBL] [Abstract][Full Text] [Related]
16. Early failure of a small-diameter high-voltage implantable cardioverter-defibrillator lead.
Hauser RG; Kallinen LM; Almquist AK; Gornick CC; Katsiyiannis WT
Heart Rhythm; 2007 Jul; 4(7):892-6. PubMed ID: 17599673
[TBL] [Abstract][Full Text] [Related]
17. Increased incidence of subacute lead perforation noted with one implantable cardioverter-defibrillator.
Danik SB; Mansour M; Singh J; Reddy VY; Ellinor PT; Milan D; Heist EK; d'Avila A; Ruskin JN; Mela T
Heart Rhythm; 2007 Apr; 4(4):439-42. PubMed ID: 17399630
[TBL] [Abstract][Full Text] [Related]
18. Increasing hazard of Sprint Fidelis implantable cardioverter-defibrillator lead failure.
Hauser RG; Hayes DL
Heart Rhythm; 2009 May; 6(5):605-10. PubMed ID: 19285920
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of Lead Failure by Recall Status and Manufacturer: Results From the Pacemaker and Implantable Defibrillator Leads Survival Study ("PAIDLESS").
Schwarzwald SN; Kersten DJ; Shaikh ZA; Needelman BS; Feldman AM; Germano J; Islam S; Cohen TJ
J Invasive Cardiol; 2018 Apr; 30(4):147-151. PubMed ID: 29610446
[TBL] [Abstract][Full Text] [Related]
20. Impact of implanted recalled sprint Fidelis lead on patient mortality.
Morrison TB; Friedman PA; Kallinen LM; Hodge DO; Crusan D; Kumar K; Hayes DL; Rea RF; Hauser RG
J Am Coll Cardiol; 2011 Jul; 58(3):278-83. PubMed ID: 21737019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
